4/20
07:23 am
pcrx
Can New EXPAREL Data and Proxy Fight Outcomes Reshape the Case For Investing In Pacira (PCRX)? [Yahoo! Finance]
Low
Report
Can New EXPAREL Data and Proxy Fight Outcomes Reshape the Case For Investing In Pacira (PCRX)? [Yahoo! Finance]
4/16
08:00 am
pcrx
Pacira to Report First Quarter 2026 Financial Results on Thursday April 30, 2026
Low
Report
Pacira to Report First Quarter 2026 Financial Results on Thursday April 30, 2026
4/13
08:00 am
pcrx
Pacira Presents Real-World Data on EXPAREL® Showing Lower Total Healthcare Costs in Outpatient Total Hip and Knee Arthroplasty Procedures
Low
Report
Pacira Presents Real-World Data on EXPAREL® Showing Lower Total Healthcare Costs in Outpatient Total Hip and Knee Arthroplasty Procedures
4/9
06:24 am
pcrx
Pacira BioSciences (PCRX) was upgraded by Zacks Research from "strong sell" to "hold".
Medium
Report
Pacira BioSciences (PCRX) was upgraded by Zacks Research from "strong sell" to "hold".
4/8
08:00 am
pcrx
Pacira BioSciences to Participate in Fireside Chat at the 25th Annual Needham Virtual Healthcare Conference
Low
Report
Pacira BioSciences to Participate in Fireside Chat at the 25th Annual Needham Virtual Healthcare Conference
3/30
08:13 am
pcrx
Pacira BioSciences to Present Real-World Data on EXPAREL® Showing Reduced Cost of Care at Orthopaedic Research Society 2026 Annual Meeting [Yahoo! Finance]
Low
Report
Pacira BioSciences to Present Real-World Data on EXPAREL® Showing Reduced Cost of Care at Orthopaedic Research Society 2026 Annual Meeting [Yahoo! Finance]
3/30
08:00 am
pcrx
Pacira BioSciences to Present Real-World Data on EXPAREL® Showing Reduced Cost of Care at Orthopaedic Research Society 2026 Annual Meeting
Low
Report
Pacira BioSciences to Present Real-World Data on EXPAREL® Showing Reduced Cost of Care at Orthopaedic Research Society 2026 Annual Meeting
3/26
08:53 am
pcrx
Pacira BioSciences (PCRX) had its price target lowered by Barclays PLC from $27.00 to $25.00. They now have an "equal weight" rating on the stock.
Low
Report
Pacira BioSciences (PCRX) had its price target lowered by Barclays PLC from $27.00 to $25.00. They now have an "equal weight" rating on the stock.
3/12
08:20 am
pcrx
DOMA Perpetual Nominates Three Highly Qualified Candidates for the Board of Pacira BioSciences, Inc.
Medium
Report
DOMA Perpetual Nominates Three Highly Qualified Candidates for the Board of Pacira BioSciences, Inc.
3/11
05:33 pm
pcrx
Pacira BioSciences Reaffirms Commitment to Shareholder Value Creation [Yahoo! Finance]
Medium
Report
Pacira BioSciences Reaffirms Commitment to Shareholder Value Creation [Yahoo! Finance]
3/11
05:02 pm
pcrx
Pacira BioSciences Reaffirms Commitment to Shareholder Value Creation
Medium
Report
Pacira BioSciences Reaffirms Commitment to Shareholder Value Creation
3/11
04:26 pm
pcrx
Pacira BioSciences, Inc. (PCRX) Presents at Barclays 28th Annual Global Healthcare Conference Transcript [Seeking Alpha]
Medium
Report
Pacira BioSciences, Inc. (PCRX) Presents at Barclays 28th Annual Global Healthcare Conference Transcript [Seeking Alpha]
3/11
01:24 pm
pcrx
DOMA Perpetual Nominates Three Highly Qualified Candidates for the Board of Pacira BioSciences, Inc. [Yahoo! Finance]
Low
Report
DOMA Perpetual Nominates Three Highly Qualified Candidates for the Board of Pacira BioSciences, Inc. [Yahoo! Finance]
3/11
01:06 pm
pcrx
DOMA Perpetual Nominates Three Highly Qualified Candidates for the Board of Pacira BioSciences, Inc.
Low
Report
DOMA Perpetual Nominates Three Highly Qualified Candidates for the Board of Pacira BioSciences, Inc.
3/11
07:18 am
pcrx
Pacira BioSciences (PCRX) was downgraded by Zacks Research from "hold" to "strong sell".
Low
Report
Pacira BioSciences (PCRX) was downgraded by Zacks Research from "hold" to "strong sell".
3/6
08:00 am
pcrx
Pacira BioSciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Low
Report
Pacira BioSciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
3/4
08:00 am
pcrx
Pacira BioSciences to Participate in Fireside Chat at the Barclays 28th Annual Global Healthcare Conference
Medium
Report
Pacira BioSciences to Participate in Fireside Chat at the Barclays 28th Annual Global Healthcare Conference
3/2
08:00 am
pcrx
Pacira BioSciences Presents Two Real-World Studies from Its Innovations in Genicular Outcomes Registry (IGOR)
Low
Report
Pacira BioSciences Presents Two Real-World Studies from Its Innovations in Genicular Outcomes Registry (IGOR)
2/28
04:32 am
pcrx
Assessing Pacira BioSciences (PCRX) Valuation After Recent Share Price Weakness [Yahoo! Finance]
Low
Report
Assessing Pacira BioSciences (PCRX) Valuation After Recent Share Price Weakness [Yahoo! Finance]
2/27
01:35 am
pcrx
Pacira BioSciences Q4 Earnings Call Highlights [Yahoo! Finance]
Low
Report
Pacira BioSciences Q4 Earnings Call Highlights [Yahoo! Finance]
2/26
08:07 pm
pcrx
Pacira BioSciences, Inc. (PCRX) Q4 2025 Earnings Call Transcript [Seeking Alpha]
Low
Report
Pacira BioSciences, Inc. (PCRX) Q4 2025 Earnings Call Transcript [Seeking Alpha]
2/26
04:22 pm
pcrx
Pacira BioSciences Reports Fourth Quarter and Full-Year 2025 Financial Results [Yahoo! Finance]
Low
Report
Pacira BioSciences Reports Fourth Quarter and Full-Year 2025 Financial Results [Yahoo! Finance]
2/26
04:01 pm
pcrx
Pacira BioSciences Reports Fourth Quarter and Full-Year 2025 Financial Results
Medium
Report
Pacira BioSciences Reports Fourth Quarter and Full-Year 2025 Financial Results
2/12
04:01 pm
pcrx
Pacira to Report 2025 Financial Results on Thursday February 26, 2026
Low
Report
Pacira to Report 2025 Financial Results on Thursday February 26, 2026
2/12
08:00 am
pcrx
Pacira Highlights New NOPAIN Act Survey Data Conducted by Voices for Non-Opioid Choices
Low
Report
Pacira Highlights New NOPAIN Act Survey Data Conducted by Voices for Non-Opioid Choices